Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9646364 | Schizophrenia Research | 2005 | 13 Pages |
Abstract
Among previously “stable,” nonremitted patients, many achieved symptom remission after long-acting, injectable risperidone treatment, with significant improvements in multiple symptom domains and patient-rated health status. These results warrant further study as these remission criteria may represent a meaningful clinical endpoint and an important step towards functional recovery.
Keywords
Related Topics
Life Sciences
Neuroscience
Behavioral Neuroscience
Authors
Robert A. Lasser, Cynthia A. Bossie, Georges M. Gharabawi, John M. Kane,